Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$271.6 - $314.21 $3.64 Million - $4.21 Million
-13,413 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $11,267 - $12,641
41 Added 0.31%
13,413 $3.78 Million
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $57,930 - $63,972
-230 Reduced 1.69%
13,372 $3.69 Million
Q1 2021

May 17, 2021

SELL
$204.88 - $255.03 $614,230 - $764,579
-2,998 Reduced 18.06%
13,602 $3.47 Million
Q4 2020

Feb 16, 2021

SELL
$186.91 - $214.42 $114,388 - $131,225
-612 Reduced 3.56%
16,600 $3.38 Million
Q3 2020

Nov 16, 2020

SELL
$167.03 - $201.3 $59,295 - $71,461
-355 Reduced 2.02%
17,212 $3.24 Million
Q2 2020

Aug 14, 2020

SELL
$113.31 - $182.44 $47,023 - $75,712
-415 Reduced 2.31%
17,567 $2.92 Million
Q1 2020

May 15, 2020

BUY
$104.32 - $195.28 $1.66 Million - $3.11 Million
15,936 Added 778.89%
17,982 $2.27 Million
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $334,480 - $355,206
2,046 New
2,046 $346,000
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $5.14 Million - $6.17 Million
-35,666 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $214,866 - $271,493
-1,737 Reduced 4.64%
35,666 $5.46 Million
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $561,208 - $808,648
-4,645 Reduced 11.05%
37,403 $4.73 Million
Q3 2018

Nov 14, 2018

SELL
$167.67 - $188.27 $96,410 - $108,255
-575 Reduced 1.35%
42,048 $7.3 Million
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $11,864 - $14,016
-74 Reduced 0.17%
42,623 $7.65 Million
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $6.9 Million - $7.6 Million
42,697 New
42,697 $6.91 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Leuthold Group, LLC Portfolio

Follow Leuthold Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leuthold Group, LLC with notifications on news.